Cardiac surgery in a girl with trisomy 13

P Strømme1, E Thaulow, O Geiran

  • 1Department of Paediatrics, Rikshospitalet, The National Hospital, Oslo, Norway. petter-stromme@adelaide.edu.au

Cardiology in the Young
|December 16, 2000
PubMed

Insights

Trisomy 13 caused severe developmental delays and multiple anomalies in an infant. Surgical repair of a ventricular septal defect improved her condition despite her eventual passing.

Area of Science:

  • Genetics
  • Pediatric Cardiology
  • Developmental Pediatrics

Background:

  • Trisomy 13 (Patau syndrome) is a severe chromosomal disorder associated with multiple congenital anomalies and intellectual disability.
  • Congenital heart defects are common in infants with trisomy 13, often contributing to significant morbidity and mortality.

Observation:

  • A profoundly retarded infant girl presented with multiple anomalies characteristic of trisomy 13.
  • The infant experienced heart failure refractory to medical management.

Findings:

  • A ventricular septal defect was successfully surgically repaired at three months of age.
  • The infant survived until 10 months of age, suggesting potential benefits from the cardiac intervention.

Implications:

  • Surgical intervention for congenital heart defects in infants with trisomy 13 may offer clinical benefits, even in the presence of profound developmental delays.
  • This case highlights the complex management challenges and the potential impact of palliative cardiac surgery in trisomy 13.
  • Further research is warranted to evaluate the long-term outcomes and quality of life for trisomy 13 patients undergoing cardiac surgery.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Meiosis I03:20

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by a...